论文信息 - Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease. - 字舞流文

Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease.

T. Fleming | B. Psaty | D. Siscovick | C. Furberg | T. Koepsell | E. Wagner | S. Heckbert | F. Rosendaal | N. Weiss | R. Kaplan | N. Smith | D. Lin | Edward H. Wagner | R. C. Kaplan | Danyu Lin | B. Psaty | T. Fleming